However, some studies have reported that FGF2 was up-regulated in thyroid cancer [33] and SLC2A5 was up-regulated in lung adenocarcinoma [34], which was inconsistent with our results may be due to the different cancer type and genetic background. The gene discussed is SLC2A5; the disease is lung adenocarcinoma.